FDA
-
-
-
-
-
-
-
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
-
-
-
-
-
-
-
AC Immune SA (ACIU) ACI-24.060 Shows Positive Initial Interim Safety and Immunogenicity
-
-
-
-
-
-
-
Pre-Open Movers 09/23: (MNOV) (ATHX) (NKE) Higher; (ACIU) (WVE) (SFIX) Lower (more...)
-
-
-
322,212 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

